olaparib,abiraterone
astrazeneca,merck
['gu ', 'crpc', 'propel', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
just conducted our last interview of gu with noel w. clarke, phd, of on final overall survival analysis from the propel study in mcrpc. for a more in-depth look at this trial and many others, check out our website! #gu23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.